I. Volosenco

SMPDL3b modulates insulin receptor signaling in diabetic kidney disease

R. Inagi, A. Mendez, T. Yoo, 2019, Nature Communications.

SMPDL3b modulates insulin receptor signaling in diabetic kidney disease

R. Inagi, A. Mendez, T. Yoo, 2019, Nature Communications.

Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis.

M. Kretzler, A. Mendez, A. Fornoni, 2018, Kidney international.